Merck Sharp & Dohme’s
MDS is a research-intensive biopharmaceutical company that develops important medicines and vaccines.
Singapore OKs molnupiravir for COVID-19 treatment
Singapore OKs molnupiravir for COVID-19 treatment
The drug is the second oral antiviral medicine authorised for COVID-19 treatment.
Most Read
1. Singapore to raise 37,000 public healthcare workers’ salaries by mid-2025 2. Global healthcare fluid connectors market to be valued at $3.5b by 2030 3. Interventional oncology market to be valued at $4.24b by 2029 4. Can Trump-backed Stargate project beat ‘The Big C’? 5. India to fully exempt 36 'life-saving' drugs from basic customs dutyResource Center
Read Here
Advertise
Sign Up
Awards
Apr
10
Events
Event News
She shared how healthcare leaders can balance innovation, governance, and patient outcomes to tackle challenges and drive transformation.
